China steps up COVID-19 vaccination, considers differentiated visa policies

China steps up COVID-19 vaccination, considers differentiated visa policies
China steps up COVID-19 vaccination, considers differentiated visa policies

You are now following the details of the China steps up COVID-19 vaccination, considers differentiated visa policies news and now we leave you with the details

Mohamed Nass - Cairo - BEIJING (Reuters) – China had administered 74.96 million doses of COVID-19 vaccines as of Saturday, health commission spokesman Mi Feng said at a news briefing on Sunday.

That compared with about 65 million doses administered as of March 14, or an additional 10 million vaccinations in less in a week, as the country accelerates its inoculation drive with the aim to inoculate 40% of its 1.4 billion population by the middle of the year.

Over 70 million doses of Sinovac Biotech’s shot have been administered globally so far, a company spokesman said during the news conference on Sunday. He did not say how many of those had been administered in China.

Beijing is also considering implementing differentiated policies for visa issuance, flights and controls on the numbers of people arriving in China based on vaccination progress and the COVID-19 situations in the countries of origin.

“We do not exempt vaccinated people from testing and isolation measures for the time being,” said Feng Zijian, vice director of Chinese Center for Disease Control and Prevention during the news conference.

However, he said China will pay attention to international progress in “vaccine passport” development and could adjust virus curbing measures after the domestic population reaches a high level of immunisation.

China’s full-year vaccine production can fully meet the needs of entire country, said Ministry of Industry and Information Technology official Mao Junfeng.

He said the supply of materials for vaccine production, including glass vials and syringes, is “relatively stable”.

China has approved four locally developed vaccines for general public use from Sinovac, CanSino Biologics and two units of China National Pharmaceutical Group (Sinopharm).

A fifth vaccine developed by the Institute of Microbiology of Chinese Academy of Sciences (IMCAS) was also approved for emergency use last week.

Reporting by Roxanne Liu and Ryan Woo; Editing by William Mallard and Sam Holmes

Our Standards: The Thomson Reuters Trust Principles.

Image; FILE PHOTO: A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed China flag in this illustration taken, October 30, 2020. REUTERS/Dado Ruvic

These were the details of the news China steps up COVID-19 vaccination, considers differentiated visa policies for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at egypt independent and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Israel resumes indoor mask requirement amid virus spike
NEXT Alpha, Beta, Gamma, Delta — WHO uses Greek alphabet to name COVID-19 variants